Continuous live cell sequencing (Liveseq GEN2)

• Unité de recherche: INNOSUISSE
• Numéro de projet: 128.644 IP-LS
• Titre du projet anglais: Continuous live cell sequencing (Liveseq GEN2)

Mots-clé (Anglais)

Life sciences, Biotechnology and processing

Résumé des résultats (Abstract) (Anglais)

Next-generation live-seq platform combining EPFL's expertise with Cytosurge's FluidFM technology. Delivers a technological breakthrough culminating in a 70X throughput improvement, enabling radical business transformation from niche equipment provider into a data-driven life-science company.